ALPELISIB vs ALPROSTADIL: Which Drug Is Safer?
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
ALPELISIB vs ALPROSTADIL: Safety Overview
| Metric | ALPELISIB | ALPROSTADIL |
|---|---|---|
| Total FAERS Reports | 8,419 | 2,800 |
| Deaths Reported | 1,271 | 60 |
| Death Rate | 15.1% | 2.1% |
| Hospitalizations | 1,705 | 210 |
| Average Patient Age | 58.8 yrs | 62.5 yrs |
| % Female Patients | 94.7% | 4.9% |
| FDA Approval Date | Apr 24, 2024 | Approved Prior to Jan 1, 1982 |
| Manufacturer | Novartis Pharmaceuticals Corporation | ENDO USA, Inc. |
| Route | ORAL | INTRACAVERNOUS |
| Marketing Status | Prescription | Prescription |